Insider Buying Disclosed on 10/16/2024
An insider trade is a stock transaction involving an individual who is involved with the company itself and has non-public information about the company. A company insider could be a major shareholder, a board member, or an executive. Insiders often sell stocks simply to realize gains, but insider trading can also be an indicator of insiders' beliefs about the company's future prospects. For example, if many insiders are purchasing shares of a company, they may believe that the company will have strong future earnings and that the share price will increase soon.
| Company | Insider Name | Buy/Sell | Shares Bought/Sold | Total Transaction | Shares Held After Transaction | Transaction Date | Actions |
|---|
KFS Kingsway Financial Services Inc. | John Taylor Fitzgerald
CEO | Buy | 284 | $2,502.04 | 1,525,192 | 10/15/2024 |  |
KFS Kingsway Financial Services Inc. | Kent A. Hansen
CFO | Buy | 178 | $1,568.18 | 126,665 | 10/15/2024 | |
GALT Galectin Therapeutics Inc. | Kevin D. Freeman
Director | Buy | 5,000 | $13,500.00 | 33,469 | 10/16/2024 | |
TTSH Tile Shop Holdings, Inc. | Fund 1 Investments, Llc
Major Shareholder | Buy | 16,000 | $105,280.00 | 7,979,669 | 10/14/2024 | |
ZVRA Zevra Therapeutics, Inc. | Corey Michael Watton
Director | Buy | 500 | $3,960.00 | 1,500 | 10/11/2024 | |
UTG Reaves Utility Income Fund | Joellen Legg
Director | Buy | 300 | $9,789.00 | 2,565 | 10/15/2024 | |
RQI Cohen & Steers Quality Income Realty Fund, Inc. | Mathew Kirschner
Portfolio Manager | Buy | 5,380 | $75,427.60 | 5,380 | 10/16/2024 | |
APRE Aprea Therapeutics, Inc. | Marc Duey
Director | Buy | 190 | $490.20 | 210,113 | 10/14/2024 | |
This page was last refreshed on Wednesday at 07:35 PM ET.
